'However, Mizoram has remained a source of concern.'
COVID has a new look.
Overall, 19 instances have decreased across India, including in Kerala, but Mizoram remains a high-risk state, according to V.K. Paul, (member) Health, Niti Aayog.
"Mizoram remains a state of worry, notwithstanding the fact that new cases are dropping across India and especially in Kerala." We must be cautious in the following two to three months to avoid an increase in COVID-19 instances. We ask that everyone be cautious in the approaching quarter. "We're relieved to see the number of instances levelling off," he added.
"We know that the festivals are coming, and a sudden increase in population density creates a conducive environment for viral spread," Balram Bhargava, Director-General of the Indian Council of Medical Research (ICMR), said, adding that the public should travel and celebrate safely during the festive season, and adhere to vaccine acceptance and COVID-19 appropriate behaviour. He went on to say, "The requirement of the hour is to conduct properly."
In giving an overview of the present COVID-19 status in India, Health Secretary Rajesh Bhushan stated that the country is experiencing an overall drop. "For the eleventh week in a row, weekly optimism is less than 3%.There is now just one state with more than one lakh active cases."
"States and Union Territories such as Lakshadweep, Chandigarh, Goa, and Himachal Pradesh have reported 100% vaccination coverage of the first dose for their populations over 18 years old." He claims that 20% of the population over the age of 18 is completely immunised.
Mr. Bhushan went on to say that there were 3,631 pressure swing adsorption (PSA) units available for medical oxygen, with 1,595 already operational.
In response to the spike in dengue cases in some regions of the nation, he remarked that following the monsoons, water accumulates, resulting in the birth of Aedes mosquitoes, which are responsible for dengue epidemics. "Every year, all states reduce their emissions. Dengue outbreaks have been reported in Delhi, Haryana, West Bengal, Uttar Pradesh, Gujarat, and Assam. He explained that "established guidelines are being observed."
Bhushan said the Zydus Cadila vaccine would not be sold on the market because it has received EUA, but it will be included in the immunisation programme. "We are in discussions with the vaccine producers on the price at which it will be purchased." Because this is a three-dose vaccination that also includes a needleless delivery mechanism, it will be priced differently," Bhushan said.
The booster dosage, according to Bhargava, is no longer necessary because the adult population has to be completely vaccinated. "At this time, talk about a booster dosage is irrelevant. In India, especially Bangalore, some research is being done out.
Some hospitals had examined at the antibodies and discovered that more than 95% of the antibodies last for even more than a year, so the concept of a boosting dosage is irrelevant."
Meanwhile, the Ministry of Health has issued a comprehensive SOP to States/UTs dated September 21 to restrict large gatherings in containment zones and districts with more than 5% case positive. It advised allowing meetings with prior approvals and limiting the number of persons in areas with a positive percentage of 5% or less.
According to the Health Ministry, India gave 62.21 lakh vaccine doses on Thursday until 8:00 p.m., bringing the total number of vaccines to 88.9 crore.
You must be logged in to post a comment.